Skip Navigation


Human Molecular Genetics Advance Access originally published online on February 22, 2007
Human Molecular Genetics 2007 16(6):609-617; doi:10.1093/hmg/ddm001
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
16/6/609    most recent
ddm001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Google Scholar
Right arrow Articles by Shepard, A. R.
Right arrow Articles by Clark, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shepard, A. R.
Right arrow Articles by Clark, A. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure

Allan R. Shepard1,*,{dagger}, Nasreen Jacobson1,{dagger}, J. Cameron Millar1, Iok-Hou Pang1, H. Thomas Steely1, Charles C. Searby3, Val C. Sheffield2,3, Edwin M. Stone2,4 and Abbot F. Clark1

1 Glaucoma Research, Alcon Research, Ltd., 6201 South Freeway, Fort Worth, TX 76134, USA, 2 Howard Hughes Medical Institute, University of Iowa, Iowa City, IA 52242, USA, 3 Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA and 4 Department of Ophthalmology, University of Iowa, Iowa City, IA 52242, USA

* To whom correspondence should be addressed. Tel: +1 8176152312; Fax: +1 8175687553; Email: allan.shepard{at}alconlabs.com

Received January 3, 2007; Accepted January 9, 2007

Glaucoma is a leading cause of worldwide irreversible visual impairment and blindness and is a clinically and genetically heterogenous group of optic neuropathies. Specific mutations in the myocilin (MYOC) gene cause primary open angle glaucoma (POAG) with varying age-of-onset and degree of severity. We show a mutation-dependent, gain-of-function association between human myocilin and the peroxisomal targeting signal type 1 receptor (PTS1R). There was correlation between the glaucoma phenotype and the specific MYOC mutations, with the more severe early-onset POAG mutations having a higher degree of association with PTS1R. Expression of human myocilin glaucomatous mutations in mouse eyes causes elevated intraocular pressure, which is a major phenotype of MYOC glaucoma. This is the first demonstration of a disease resulting from mutation-induced exposure of a cryptic signaling site that causes mislocalization of mutant protein to peroxisomes and the first disease-gene-based animal model of human POAG.


{dagger} The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
Y. Zhou, O. Grinchuk, and S. I. Tomarev
Transgenic Mice Expressing the Tyr437His Mutant of Human Myocilin Protein Develop Glaucoma
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1932 - 1939.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W.-H. Wang, L. G. McNatt, I.-H. Pang, P. E. Hellberg, J. H. Fingert, M. D. McCartney, and A. F. Clark
Increased Expression of Serum Amyloid A in Glaucoma and Its Effect on Intraocular Pressure
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1916 - 1923.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.